DIMENSIONAL FUND ADVISORS LP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 160 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$174,000
+14.5%
23,5700.0%0.00%
Q4 2021$152,000
+10.9%
23,5700.0%0.00%
Q3 2021$137,000
-45.0%
23,570
-2.1%
0.00%
Q2 2021$249,000
-83.9%
24,084
-83.6%
0.00%
-100.0%
Q1 2021$1,542,000
-32.0%
146,6030.0%0.00%0.0%
Q4 2020$2,269,000
-77.7%
146,603
-79.0%
0.00%
-75.0%
Q3 2020$10,185,000
-31.1%
697,608
-10.7%
0.00%
-33.3%
Q2 2020$14,787,000
-29.3%
780,850
-28.3%
0.01%
-45.5%
Q1 2020$20,923,000
-7.4%
1,089,102
-7.6%
0.01%
+37.5%
Q4 2019$22,606,000
+94.2%
1,179,239
-2.6%
0.01%
+60.0%
Q3 2019$11,643,000
+75.9%
1,210,267
+9.5%
0.01%
+66.7%
Q2 2019$6,618,000
+0.3%
1,104,850
-2.2%
0.00%0.0%
Q1 2019$6,599,000
+4.5%
1,129,958
+67.7%
0.00%0.0%
Q4 2018$6,313,000
+42.4%
673,774
+158.8%
0.00%
+50.0%
Q3 2018$4,434,000
-15.4%
260,365
-15.6%
0.00%0.0%
Q2 2018$5,239,000
+24.6%
308,356
-1.6%
0.00%0.0%
Q1 2018$4,205,000
+38.6%
313,356
-0.8%
0.00%
+100.0%
Q4 2017$3,033,000
-13.4%
315,890
-1.0%
0.00%
-50.0%
Q3 2017$3,503,000
+19.6%
319,042
-1.4%
0.00%
+100.0%
Q2 2017$2,930,000
-17.3%
323,671
+17.3%
0.00%
-50.0%
Q1 2017$3,543,000
+44.4%
275,972
+5.7%
0.00%
+100.0%
Q4 2016$2,454,000
+332.0%
261,055
+347.5%
0.00%
Q3 2016$568,00058,3410.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders